Axsome Malta Ltd and SK Biopharmaceuticals Secure Patent for Treatment of Cataplexy

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Global IP News (India), December 13, 2024 Pharmaceutical Patent News, 2pp
  • Additional Information
    • Abstract:
      Alexandria, Dec. 13 -- Axsome Malta Ltd and SK Biopharmaceuticals have secured a patent on treatment of cataplexy. Khayrallah Moise A, Bream Gary and Butts Stephen E developed the invention. The patent application number is US202318337299 20230619. The patent publication number is US12162821 (B2). International Patent Classification codes are A61K31/27, A61K31/325, A61K45/06, A61K9/00, A61K9/20, C07C271/00 and C07C271/02...